As of April 16, 2025, Atai Life Sciences (ATAI) has a market cap of $0.28 billion USD. According to our data, Atai Life Sciences is ranked No.6611 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.28 B |
6.83%
|
Dec 31, 2024 | $0.26 B |
-5.67%
|
Dec 29, 2023 | $0.27 B |
-46.99%
|
Dec 30, 2022 | $0.52 B |
-65.14%
|
Dec 31, 2021 | $1.48 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() COMPASS Pathways
CMPS
|
$0.28 B |
-0.000 M
|
![]() UK
|
![]() Mind Medicine
MNMD
|
$0.42 B |
0.000 M
|
![]() USA
|
![]() Cybin
CYBN
|
$0.16 B |
0.000 M
|
![]() Canada
|
![]() GH Research
GHRS
|
$0.56 B |
-0.000 M
|
![]() Ireland
|
![]() Seelos Therapeutics
SEEL
|
$0.21 M |
0.023 M
|
![]() USA
|
![]() Atai Life Sciences
ATAI
|
$0.28 B |
0.000 M
|
![]() Germany
|
Market Cap | = | ATAI Stock Price | * | ATAI Shares Outstanding |
= | $1.39 | * | 0.20 B | |
= | $0.28 B |